CBT Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
982.0M
+8.6%
904.0M
+6.5%
849.0M
-5.6%
899.0M
-2.6%
923.0M
Cost of Revenue
798.0M
+15.0%
694.0M
+8.8%
638.0M
-6.0%
679.0M
+0.0%
679.0M
Gross Profit
184.0M
-12.4%
210.0M
-0.5%
211.0M
-4.1%
220.0M
-9.8%
244.0M
Operating Expenses
86.0M
+6.2%
81.0M
-1.2%
82.0M
-1.2%
83.0M
+7.8%
77.0M
R&D
13.0M
-7.1%
14.0M
+7.7%
13.0M
-13.3%
15.0M
+0.0%
15.0M
SG&A
73.0M
+9.0%
67.0M
-2.9%
69.0M
+1.5%
68.0M
+9.7%
62.0M
Operating Income
98.0M
-24.0%
129.0M
+0.0%
129.0M
-5.8%
137.0M
-18.0%
167.0M
EBITDA
148.0M
-16.9%
178.0M
+4.7%
170.0M
-4.0%
177.0M
-14.1%
206.0M
Net Income
14.0M
-82.1%
78.0M
-4.9%
82.0M
+51.9%
54.0M
-52.2%
113.0M
EPS (Basic)
$0.12
-90.6%
$1.27
-8.0%
$1.38
+64.3%
$0.84
-55.1%
$1.87
EPS (Diluted)
$0.12
-90.6%
$1.27
-7.3%
$1.37
+55.7%
$0.88
-52.7%
$1.86
Shares (Diluted)
52.0M
-0.4%
52.2M
-1.3%
52.9M
-1.3%
53.6M
-0.4%
53.8M
Cabot (CBT) โ€” Financials